I'm LongbridgeAI, I can summarize articles.Oppenheimer analyst Matthew Biegler maintained a Buy rating on Tyra Bioscience (TYRA) with a $50 price target. Additionally, JonesTrading initiated coverage with a Buy rating and a $56 price target.
In a report released today, Matthew Biegler from Oppenheimer maintained a Buy rating on Tyra Bioscience, with a price target of $50.00.
Claim 55% Off TipRanks
- Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions.
- Discover top stock picks and new investment opportunities through TipRanks' Smart Investor Newsletter.
According to TipRanks, Biegler is a 3-star analyst with an average return of 1.3% and a 37.72% success rate. Biegler covers the Healthcare sector, focusing on stocks such as Gilead Sciences, Biomea Fusion, and Relay Therapeutics.
In a report released today, JonesTrading also initiated coverage with a Buy rating on the stock with a $56.00 price target.